Machine learning models in the prediction of 1-year mortality in patients with advanced hepatocellular cancer on immunotherapy: a proof-of-concept study

被引:0
作者
Thomas Ka Luen Lui
Ka Shing Cheung
Wai Keung Leung
机构
[1] University of Hong Kong,Department of Medicine
来源
Hepatology International | 2022年 / 16卷
关键词
Artificial intelligence; Hepatocellular carcinoma; Immunotherapy; Machine learning; Mortality; Nivolumab; Pembrolizumab; Ipilimumab; Gradient boosting; Random forest;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:879 / 891
页数:12
相关论文
共 161 条
[1]  
Fitzmaurice C(2019)Global, Regional, and National Cancer Incidence, Mortality, Years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study JAMA Oncol 5 1749-1768
[2]  
Abate D(2021)Real-world systemic sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea Invest New Drugs 39 260-268
[3]  
Abbasi N(2021)Advances in immunotherapy for hepatocellular carcinoma Nat Rev Gastroenterol Hepatol 2018 1-15
[4]  
Lee MJ(2018)Immunotherapy for hepatocellular carcinoma: current advances and future expectations J Immunol Res 12 1-15
[5]  
Chang SW(2020)Recent advances in immunotherapy for hepatocellular carcinoma Cancers (Basel) 26 e1036-e1049
[6]  
Kim JH(2021)The role of immunotherapy in hepatocellular carcinoma: a systematic review and pooled analysis of 2,402 patients Oncologist 382 1583-1586
[7]  
Sangro B(2020)Prediction models—development, evaluation, and clinical application N Engl J Med 8 1687-1695
[8]  
Sarobe P(2020)Real-world integration of a sepsis deep learning technology into routine clinical care: implementation study JMIR Med Inform 382 1-14
[9]  
Hervas-Stubbs S(2020)Artificial intelligence to detect papilledema from ocular fundus photographs N Engl J Med 90 E514-E520
[10]  
Melero I(2018)A review of statistical and machine learning methods for modeling cancer risk using structured clinical data Artif Intell Med 7 864-872